News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ReGen Biologics, Inc. (RGBI) Responds to FDA Request for Additional Information on Pending 510(k)



6/27/2007 2:59:48 AM

FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--ReGen Biologics (OTC: RGBI) today announced that the Company has recently responded to the FDA’s request for additional information regarding the Company’s December 2006 510(k) pre-market notification for its collagen scaffold device.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES